Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox

Fungal infections impact the lives of at least 12 million people every year, killing over 1.5 million. Wide-spread use of fungicides and prophylactic antifungal therapy have driven resistance in many serious fungal pathogens, and there is an urgent need to expand the current antifungal arsenal. Rece...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Aidan Kane, Dee A. Carter
Format:	Artykuł
Język:	English
Wydane:	MDPI AG 2022-04-01
Seria:	Pharmaceuticals
Hasła przedmiotowe:	antifungal azole synergy mycosis resistance <i>Candida</i>
Dostęp online:	https://www.mdpi.com/1424-8247/15/4/482

Podobne zapisy

Spectrum of activity and mechanisms of azole–bisphosphonate synergy in pathogenic Candida
od: Aidan Kane, i wsp.
Wydane: (2024-06-01)

Fungal Diseases in Elasmobranchs and Their Possible Treatment with a Special Mention to Azole Antifungal Agents
od: Daniela Cañizares-Cooz, i wsp.
Wydane: (2023-12-01)

Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds
od: Aidan Kane, i wsp.
Wydane: (2024-06-01)

Synthesis, Copper(II) Binding, and Antifungal Activity of Tertiary <i>N</i>-Alkylamine Azole Derivatives
od: Teresa Pissarro, i wsp.
Wydane: (2024-09-01)

Antifungal activity of nisin against clinical isolates of azole-resistant Candida tropicalis
od: Shuo Gao, i wsp.
Wydane: (2024-05-01)

Pyrvinium Pamoate Synergizes with Azoles in vitro and in vivo to Exert Antifungal Efficacy Against Candida auris and Other Candida Species
od: Zhang J, i wsp.
Wydane: (2025-02-01)

Changing pattern of antifungal drug resistance in a tertiary health-care facility – A cross-sectional study
od: Satabdi Sahu, i wsp.
Wydane: (2023-01-01)

Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic <i>Candida</i> Species
od: Karolina M. Czajka, i wsp.
Wydane: (2023-11-01)

New Antifungal Agents with Azole Moieties
od: Melissa Martins Teixeira, i wsp.
Wydane: (2022-11-01)

In Vitro Biofilm Formation by <i>Malassezia pachydermatis</i> Isolates and Its Susceptibility to Azole Antifungals
od: Eva Čonková, i wsp.
Wydane: (2022-11-01)

Azole-Based Compounds That Are Active against <i>Candida</i> Biofilm: In Vitro<i>,</i> In Vivo and In Silico Studies
od: Simone Carradori, i wsp.
Wydane: (2022-10-01)

Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit <i>Candidozyma auris</i>
od: Stephanie Toepfer, i wsp.
Wydane: (2024-10-01)

Resurgence and Repurposing of Antifungal Azoles by Transition Metal Coordination for Drug Discovery
od: Youri Cortat, i wsp.
Wydane: (2023-09-01)

Antimicrobial Peptides: Avant-Garde Antifungal Agents to Fight against Medically Important <i>Candida</i> Species
od: Gina P. Rodríguez-Castaño, i wsp.
Wydane: (2023-02-01)

A Preliminary in vitro and in vivo Evaluation of the Effect and Action Mechanism of 17-AAG Combined With Azoles Against Azole-Resistant Candida spp.
od: Luyao Liu, i wsp.
Wydane: (2022-07-01)

Continual Decline in Azole Susceptibility Rates in Candida tropicalis Over a 9-Year Period in China
od: Yao Wang, i wsp.
Wydane: (2021-07-01)

Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic <italic toggle="yes">Candida</italic> Species
od: Nicole M. Revie, i wsp.
Wydane: (2020-04-01)

Antifungal Resistance in Clinical Isolates of <i>Candida glabrata</i> in Ibero-America
od: Erick Martínez-Herrera, i wsp.
Wydane: (2021-12-01)

Virulence Traits and Azole Resistance in Korean <i>Candida auris</i> Isolates
od: Seung A. Byun, i wsp.
Wydane: (2023-09-01)

CORRELATE BETWEEN BIOFILM FORMATION AND AZOLE ANTIFUNGAL SUSCEPTIBILITY AGAINST PLANKTONIC AND SESSILE CANDIDA ALBICANS CLINICAL ISOLATES
od: Saira Salim, i wsp.
Wydane: (2021-06-01)

Antifungal agents: Polyene, azole, antimetabolite, other and future agents
od: Fardin Ali Malayeri, i wsp.
Wydane: (2018-03-01)

Antifungal resistance: current trends and future strategies to combat
od: Wiederhold NP
Wydane: (2017-08-01)

Role of Antifungal Combinations in Difficult to Treat <i>Candida</i> Infections
od: Roxana G. Vitale
Wydane: (2021-09-01)

Antifungal azole metabolites: Significance in pharmaceutical and biomedical analysis
od: Kokil Sachin, i wsp.
Wydane: (2009-01-01)

Detecting Azole-Antifungal Resistance in <i>Aspergillus fumigatus</i> by Pyrosequencing
od: Mireille H. van der Torre, i wsp.
Wydane: (2020-01-01)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
od: Venkatesh Mayandi, i wsp.
Wydane: (2023-03-01)

Phase-Dependent Differential In Vitro and Ex Vivo Susceptibility of <i>Aspergillus flavus</i> and <i>Fusarium keratoplasticum</i> to Azole Antifungals
od: Darby Roberts, i wsp.
Wydane: (2023-09-01)

Effect of Escin Alone or in Combination with Antifungal Agents on Resistant <i>Candida glabrata</i> Biofilms: Mechanisms of Action
od: Angela Maione, i wsp.
Wydane: (2023-07-01)

Study on the Antifungal Activity of Gallic Acid and Its Azole Derivatives against <i>Fusarium graminearum</i>
od: Yilin Zheng, i wsp.
Wydane: (2024-04-01)

Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?
od: Sarah Berger, i wsp.
Wydane: (2017-06-01)

Silver(I) Complexes with Clinically Used Azoles: Synthesis, Structural Characterization and Antimicrobial Evaluation
od: Nevena Lj. Stevanović, i wsp.
Wydane: (2022-11-01)

Reversal of azole resistance in Candida albicans by oridonin
od: Haisheng Chen, i wsp.
Wydane: (2021-03-01)

Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China
od: Yao D, i wsp.
Wydane: (2019-04-01)

Enhanced Tolerance to Antifungals as a General Feature of Rho<sup>−</sup> Mutants in Yeast Species: Implications to Positive Selection of Respiratory Deficiency
od: Zachary Johnson, i wsp.
Wydane: (2025-01-01)

The Risk Factors and Mechanisms of Azole Resistance of <i>Candida tropicalis</i> Blood Isolates in Thailand: A Retrospective Cohort Study
od: Teera Leepattarakit, i wsp.
Wydane: (2022-09-01)

Essential Oil-Based Design and Development of Novel Anti-<i>Candida</i> Azoles Formulation
od: Rania Hamdy, i wsp.
Wydane: (2020-03-01)

An Azole-Resistant Candida parapsilosis Outbreak: Clonal Persistence in the Intensive Care Unit of a Brazilian Teaching Hospital
od: Danilo Yamamoto Thomaz, i wsp.
Wydane: (2018-12-01)

Attempts to Access a Series of Pyrazoles Lead to New Hydrazones with Antifungal Potential against <i>Candida</i> species including Azole-Resistant Strains
od: Georgiana Negru, i wsp.
Wydane: (2021-09-01)

Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
od: Philip E. Alabi, i wsp.
Wydane: (2023-08-01)

Environmental Clonal Spread of Azole-Resistant <i>Candida parapsilosis</i> with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center
od: Danilo Y. Thomaz, i wsp.
Wydane: (2021-03-01)